Quarterly Statement Of Cash Flows

BrightPath Biotherapeutics Co., Ltd. - Filing #7559979

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,483,733,000 JPY
-1,481,772,000 JPY
Depreciation
16,719,000 JPY
35,123,000 JPY
Impairment losses
9,958,000 JPY
5,701,000 JPY
Interest and dividend income
-20,000 JPY
-27,000 JPY
Loss (gain) on sale of property, plant and equipment
JPY
-13,000 JPY
Decrease (increase) in trade receivables
16,530,000 JPY
-16,302,000 JPY
Increase (decrease) in trade payables
-1,835,000 JPY
1,444,000 JPY
Other, net
238,335,000 JPY
-47,618,000 JPY
Subtotal
-1,201,800,000 JPY
-1,509,410,000 JPY
Interest and dividends received
21,000 JPY
28,000 JPY
Interest paid
-202,000 JPY
-221,000 JPY
Income taxes paid
-2,420,000 JPY
-2,420,000 JPY
Net cash provided by (used in) operating activities
-1,204,401,000 JPY
-1,512,022,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,005,000 JPY
-17,646,000 JPY
Proceeds from sale of property, plant and equipment
JPY
80,000 JPY
Net cash provided by (used in) investing activities
-1,760,000 JPY
-17,566,000 JPY
Cash flows from financing activities
Proceeds from issuance of bonds
JPY
300,000,000 JPY
Redemption of bonds
-87,500,000 JPY
-212,500,000 JPY
Purchase of treasury shares
0 JPY
JPY
Net cash provided by (used in) financing activities
432,104,000 JPY
569,226,000 JPY
Net increase (decrease) in cash and cash equivalents
-774,056,000 JPY
-960,361,000 JPY
Cash and cash equivalents
1,530,969,000 JPY
2,305,026,000 JPY
3,265,388,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.